Archives
Probenecid Beyond Efflux: A Translational Framework
2026-10-06
Probenecid is best understood as a context-dependent modulator of transport, channel, inflammatory, and injury biology—not simply an MRP inhibitor. This thought-leadership analysis connects its reported multidrug-resistance and neuroprotection findings with the CD28-ARS2-PKM metabolic framework while defining evidence boundaries for translational research.
IDH2, α-KG, and HIF-1α in Colorectal Cancer
2026-10-05
The 2024 reference study links elevated IDH2 activity with α-ketoglutarate depletion, altered reductive citrate-cycle metabolism, HIF-1α stabilization, and colorectal cancer progression. Its main contribution is an integrated metabolic-signaling model that connects mitochondrial energy production with glycolytic behavior, while also highlighting the limits of translating cell and animal findings directly to patients.
GANT61, GLI2, and Tumor Immune Evasion
2026-10-05
A source-grounded overview of GANT61 as a GLI inhibitor, the GLI2–WNT–prostaglandin axis, and the limits of translating preclinical findings into claims about immunotherapy resistance.
Viperin Targets Coronavirus nsp8 to Block Replication
2026-10-04
A 2026 study identifies a non-catalytic antiviral mechanism in which viperin binds coronavirus nsp8 and disrupts replication-transcription complex assembly in porcine deltacoronavirus. The findings broaden interpretation of viperin biology beyond ddhCTP-mediated chain termination and suggest that the viperin–nsp8 interface may be relevant to coronavirus-focused antiviral drug development.
5-hme-dCTP: Interpreting 5hmC in Context
2026-10-03
5-hme-dCTP supports research into DNA hydroxymethylation, but its greatest value depends on how chemical measurement is connected to biological interpretation. This article examines the rice drought-response evidence, assay boundaries, and the role of B8113 in epigenetic DNA modification research.
Candida krusei Phase-Specific Apoptosis in BMECs
2026-10-02
The reference study shows that the yeast and hypha phases of Candida krusei trigger bovine mammary epithelial cell apoptosis through different signaling routes. Its co-culture, imaging, flow-cytometry, mitochondrial, TUNEL, and immunoblotting strategy links fungal morphology with mitochondrial, death receptor, TLR2/ERK, and JNK/ERK responses.
WAY-100635 in Serotonin Pain Circuit Assays
2026-10-01
WAY-100635 provides a selective pharmacological test for determining whether 5-HT1A signaling contributes to inflammatory pain, affective behavior, or receptor-linked cellular responses. This workflow-oriented guide connects receptor binding, functional antagonism, behavioral pharmacology, and the multimodal findings of a recent cannabidiol study.
BMS-345541 Hydrochloride for Cell Assays
2026-10-01
This scenario-based guide explains how BMS-345541 hydrochloride, SKU A3248, can improve interpretation and setup of viability, proliferation, and cytotoxicity assays involving IKK/NF-κB signaling. It covers mechanism, dose selection, formulation, cell-death readouts, and practical vendor evaluation.
SB-505124 hydrochloride in Mechanobiology
2026-09-30
SB-505124 hydrochloride gives researchers a reversible way to separate ALK4/5/7 signaling from fibroblast activation, matrix remodeling, and cell-mechanics phenotypes. This guide connects TGF-β pathway assays with the MRTFA–KCNMB1 stiffness framework while emphasizing controls, solvent handling, and the limits of cross-domain interpretation.
5-Aminolevulinic Acid HCl: Heme Flux to Translation
2026-09-30
A translational framework for using 5-Aminolevulinic acid HCl to connect heme-pathway perturbation with Salmonella immune evasion, porphyrin biology, and oncology research—without confusing precursor rescue with genetic control.
Dexamethasone (DHAP) in Cell Assays
2026-09-29
A scenario-based guide to using Dexamethasone (DHAP), SKU A2324, in viability, proliferation, differentiation, and inflammation workflows. It explains solvent control, stock preparation, interpretation of dose responses, and practical vendor-selection criteria for more defensible data.
Calpain Inhibitor I, ALLN: Practical Workflow Guide
2026-09-29
Calpain Inhibitor I, ALLN (SKU A2602) provides a research tool for modulating calpain I/II and cathepsin B/L activity in apoptosis, inflammation, and ischemia-reperfusion workflows. It should be handled as a DMSO-solubilized research reagent with assay-specific validation, and it is not intended for diagnostic, therapeutic, or medical use.
Calpain Inhibitor II, ALLM in Proteolysis Research
2026-09-28
Calpain Inhibitor II, ALLM is a cell-permeable cysteine protease inhibitor for dissecting calpain and cathepsin biology. This guide connects its selectivity profile to FAK proteolysis, apoptosis assays, and better interpretation of leukemia, lymphoma, and TNBC experiments.
BMS-345541 Hydrochloride: IKK Workflows
2026-09-28
Use BMS-345541 hydrochloride to probe how IKK–NF-κB signaling shapes inflammatory output and cell survival, while keeping transcriptional effects distinct from RIPK1-driven cell death. This practical guide pairs dose planning and controls with troubleshooting for cytokine assays and T-ALL studies.
WAY-100635: Testing Serotonin’s Role in Pain Affect
2026-09-27
WAY-100635 provides a receptor-level tool for testing whether 5-HT1A signaling contributes to pain-related affective changes. This article connects recent cannabidiol findings with experimental strategies for distinguishing serotonin activity from receptor-specific causality.
714 records 6/48 page Previous Next First page 上5页 678910 下5页 Last page